Navigation Links


Clevidipine in Medical Technology

Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery

...incorporated herein by reference. The Company specifically disclaims any obligation to update these forward-looking statements. * Evaluation of clevidipine In the Postoperative Treatment of Hypertension Assessing Safety Events ** Dr. Solomon Aronson is a paid consultant for The Medicines Comp...

Pivotal Phase III Findings With Investigational Drug Cleviprex (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery

...incorporated herein by reference. The Company specifically disclaims any obligation to update these forward-looking statements. * Evaluation of clevidipine In the Postoperative Treatment of Hypertension Assessing Safety Events ** Dr. Solomon Aronson is a paid consultant for The Medicines Comp...
Clevidipine in other areas

Clevidipine - Wikipedia, the free encyclopedia

Clevidipine is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.

The Medicines Company | Development Pipeline | Clevidipine

For acute hospital care pharmaceuticals, The Medicines Company helps meet the demands of the world's most advanced medical practitioners.

Cleviprex® (clevidipine butyrate): Official Web Site - Homepage

Cleviprex® (clevidipine butyrate injectable emulsion) rapidly reduces blood pressure and maintains blood pressure control.

Cleviprex-PI

Clevidipine butyrate was evaluated in 15 studies in ... In pregnant rats dosed with clevidipine butyrate during late gestation and ...

Clevidipine for acute hypertension

Results of a new trial with clevidipine, an investigational calcium-channel blocker with an ultrashort half-life of less than one minute, show the drug has promise ...

Clevidipine: A viable alternative to nitroglycerin, nitroprusside?

The investigational intravenous antihypertensive clevidipine is as safe as ... The Medicines Company halts phase 3 safety trial of clevidipine ...
Other TagsProbeProbeProbeProbeProbeInterest
(Date:11/27/2009)...g unprecedented medical, economic burdens, study p...ews) -- The number of people with diabetes in the ...25 years, a new study predicts. , That would br... with the disease, up from 23.7 million today. , ...ith diabetes will triple, the study also warns, ri...
(Date:11/27/2009)... Specialist manufacturers who use medical load...illions of dollars by bringing in technology partn... numbers of pro-active medical manufacturers are c... stage of their projects, ensuring that progress w...s or potentially outdated technology. , ...
(Date:11/26/2009)...s, the number of Americans living with diabetes wi...2009 to 44.1 million in 2034. Over the same period...from $113 billion to $336 billion, even with no in...ased at the University of Chicago report in the De... those with diabetes covered by Medicare will rise...
(Date:11/26/2009)... No more letters from the North Pole, Textsant...essages from Santa , Nort...rational efficiencies at the North Pole Santa Clau...en all over the globe informed of his Christmas pr...;s research department have identified a large and...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nati... and Yasmin birth control pills who have suffered ...Stroke, Heart Attack or other related cardiac issu...l toll free at 1-800-856-6405 or go to the firm&rs...l out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...
(Date:11/24/2009)...sts have crystallised a protein that may help gut ...rotein could be used by probiotic producers to ide...t to people. , "Probiotics need to interact with ...and if they attach to surfaces in the gut they are...their activity," says Dr Nathalie Juge from the In...
(Date:11/24/2009)...mic-level action of a remarkable class of ring-sha...rs with the Lawrence Berkeley National Laboratory ...ystallography beamline at the Advanced Light Sourc...n gene expression and replication, and are vital t... infectious agents, such as the human papillomavir...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3Oncothyreon to present at Rodman Renshaw Global Healthcare Conference 13822 1Echo Therapeutics to Present at Rodman 26 Renshaw 2009 Annual Global Investment Conference 56117 1Echo Therapeutics to Present at Rodman 26 Renshaw 2009 Annual Global Investment Conference 56117 2
Other Contentsprojectsprojectsprojectsprojectsprojectsprojectsprojectsprojectscomplexitycomplexitycomplexitycomplexitycomplexitycomplexitycomplexitygenomicgenomicgenomicgenomicgenomicgenomicgenomicgenomicgenotypegenotypegenotypegenotypegenotypegenotypegenusgenusgenusgenusgenusdistributiondistributiondistributiondistributiondistributiondistributiondistributiondistributiondistributiongeographicgeographicgeographicgeographicgeographicgeographic